Optibiotix Health Share Discussion Threads

[rayrac] 12/6/2019 19:46

Toyin, thats not how you get an ‘independent’ answer to a question. He’s not going to say anything but good about Opti. Which means it can only be a biased answer?!

[slartybartfaster] 12/6/2019 19:22

OK fella. Thanks.

[toyin] 12/6/2019 18:20

Slarty, I wasn't aiming the post at you it was just a generic post. I like to here both sides of the argument also, but I just think there is a lot of tosh written on here. That's why I speak to SOH to answer my questions and concerns.

[slartybartfaster] 12/6/2019 18:03

Who is being emotional? I'm not interested in a echo Chamber. I made valid points. OPTI is a fantastic opportunity for anyone with a single working braincell. OK this rules out Raywhack and just about gets me through the door.

[toyin] 12/6/2019 17:03

If you believe, buy/hold. If you dont believe, sell. I dont understand why people are getting so emotional, SOH has always said he won't give figures until he has built relationships with partners that he can trust to deliver.

The price is going to stay like this until we have figures so if you dont like the situation, sell.

[imnotlong] 12/6/2019 15:32

Were we not told last year that opti would be profitable by the end of 2018 (excluding all the SBTX accounting adjustments)? I think when last updated, SoH implied that only fixed monthly costs are being covered. So I’m now expecting a half year loss when the 6 month results are released.

It my belief that in addition to the long wait for big contracts to arrive these inconsistent messages don’t help either.

But sentiment will change at some point. Maybe even this month if SoH’s last comment that June could be better than May transpires to be true. But the news will need to be on a different scale to the usual RNS that the market ignores.

[judijudi] 12/6/2019 14:28

Funny again
:)

[someuwin] 12/6/2019 14:27

"There should be revenue forecasts here within the next 12 months which should bring some reassurance."

If we have to wait a year for revenue guidance then the share price will keep drifting down for a year - imo.

They could easily tell us now if the wanted (every deal they do has minimum sales orders so its simple maths) They just chose not to. And I suspect they're happy for finnCap not to put out any forecasts too. This speaks volumes.

[reckless kelly] 12/6/2019 13:29

Spoken like a true alien from planet 'cypress'

LOL !!

[rayrac] 12/6/2019 13:11

You can’t have it both ways slarty. One minute you say there are very few updates, and the next I should be “doing extended time to do research”.

How can you research no updates? I’ve tried two of Opti’s products. One gave me the ‘runs’ and very high bp, but did lower cholesterol. The other had no effect on appetite suppression at all!

[riskybusiness1] 12/6/2019 13:03

To be fair emotions change more often than the wind on this B.B. I agree with the lack of visibility which I mentioned in my post. The beginning of this process is similar to the ARM model where the price was frustrated by the lack of visibility. License partner models unfortunately often have this issue at early stages. There should be revenue forecasts here within the next 12 months which should bring some reassurance. Last set of results showed the early direction this is going in.

[alanrussell] 12/6/2019 12:36

Thanks Shrewd, that's what I figured, could hardly see payments reducing. However still a bit uncertain - as these are half yearly payments then presumably they also occurred in December and January i.e. in H1. And presumably they are determined by volume so why should this skew results towards H2 other than by growth? When I first read that comment a month or two back I feared it was a preliminary softening up process for underwhelming H1 numbers yet all other noises have been positive.

Don't get me wrong, I am happy to hold and am imbued with endless patience (first started this stock market lark back in "tell Sid" days). It's just that those decades of experience have rather got my antennae tuned for asides that might later be referred to as "....as reported earlier ..." when numbers disappoint!

[incanus] 12/6/2019 12:36

Ray my love, you are not in a strong position when calling investors 'pathetic' when you have no interest here other than spread lies and misinformation.

[rayrac] 12/6/2019 12:17

ARM model ffs! Get real.

[riskybusiness1] 12/6/2019 12:13

The market 'exudes' confidence in cycles. The emotions on this board & with a lot of investors in this stock is like a schizophrenic mentality. The company is overall fairly priced currently with it revenues still building from a small base & into expected profitability this year. If you step back & look at the building blocks such as now 41 deals all over the globe & now industry specific sales expertise coming in such as Fred Narbel & Steve Prescott who could drive massive revenue growth with their eyes closed in this space with these products. They were after all managing sales in excess of £100m+ in previous roles within this very space, imagine their network in the corporate world.... not sure how many times this needs to be saidPrice has dropped down on a number of days where the volume has been less that 50k shares traded. Pitiful volume which does not reflect the confidence of the overall market. I'm not sure how anyone couldn't be confident in a company signing 41 deals in around 2 years of commercialising product through multiple partners. Price action just like the ARM model before the model was proven. Frustrating price action due to lack of visibility in revenues due to building up supply chains via partner license model which quite clearly takes time to do. Bod will have clear visibility of this coming together behind the scenes which is probably why they exude confidence. Like SOH said in last interview that he's building a business not a share price & once everything all falls in to place the price will follow.

[slartybartfaster] 12/6/2019 11:22

That's great. However, it is the market that needs to exude confidence. It does not.

[shrewdmole] 12/6/2019 10:56

Nobby

Thanks for feedback from Agm.

I particularly like the fact the board exude confidence.
Keep saying it but they must have so much self control looking at the price knowing who is at the table!

S

[shrewdmole] 12/6/2019 10:52

Payments due June and July hence revenues are lumpy and h2 biased.

I suspect there is a meaty order on the bid side

[parob] 12/6/2019 10:28

Cholbiome tweet: We're excited to announce that our range of #Cholesterol management products will soon be available in Vietnam! Leading pharmaceutical & probiotics distributor, Biovagen, sign an agreement to market both CholBiome® and CholBiome®x3 for 3 years.

[bdog51] 12/6/2019 10:10

Heaps of evidence that revenue is steadily growing. If you don't like the rate of growth here then try a FTSE100 stock instead. Too many investors on AIM have soooo little patience!